Press Releases from SMi Group (942 total)
Dosage form design: Link of Dissolution, Bioequivalence and if biowaiver can be …
SMi’s masterclass on Dosage form design: Link of Dissolution, Bioequivalence and if biowaiver can be applied will be running in London on 6th December 2016.
In…
Human Factors in Device Design – Study Results on Patient Insight Unveiled at …
SMi Group are excited to have results from a recent patient study, presented at its 9th Annual Pre-Filled Syringes Europe conference when it returns to…
Agenda released for SMi’s 19th Annual Superbugs European Show Featuring Keynot …
Following on from what is set to be a successful Superbugs USA summit in two weeks’ time, SMi Group is delighted to release an agenda…
New agenda released for Paediatric Clinical Trials event returning to London in …
After 10 successful years of running, SMi’s 11th annual Paediatric Clinical Trials event will be heading back to London, UK in March 2017.
Strengthening strategies in…
Agenda released for Drug Discovery 2017 : big pharma and biotech bridge the gap
Big pharma and biotech to meet in London conference on Drug Discovery, taking place on 27th & 28th March 2017 in London.
The gap between…
Multi-Organ-on-a-Chip Technologies: potential impact on predictive substance tes …
SMi has confirmed that TissUse, leading pioneers of the Multi-Organ-Chip technology, will be joining the expert speaker lineup for the inaugural conference on 3D Cell…
Industry and Government Bodies Gather for Crucial Updates into Antibiotic Resist …
Just 3 weeks remain until SMi Group open its doors to host Superbugs & Superdrugs USA, the American installment of its long running European conference.
Following…
Challand Biosimilars Consulting joins Biosimilars North America event to provide …
SMi's 3rd annual Biosimilars North America conference will be returning to Iselin, New Jersey, USA in November 2016. This year’s event promises to bring even…
NIAID Unveils First Year Results of US Government “Combating Antibiotic Resist …
NIAID Unveils First Year Results of US Government “Combating Antibiotic Resistant Behaviour (CARB) Initiative” at Superbugs USA
In just over 4 weeks on November 14th &…
Roche Unlock the Potential of Locked Nucleic Acids
SMi Group are thrilled to have industry expert Dr Bo Rode Hansen, present a special keynote address on harnessing the potential of locked nucleic acids…
Myths that must be overcome to ensure successful commercialization of biosimilar …
SMi's 3rd annual Biosimilars North America conference will be returning to Iselin, New Jersey, USA in November 2016. This year’s event promises to bring even…
Parallel Trade for Pharma: The opportunities and challenges ahead – beyond FMD …
SMi Group is delighted to announce: 11th annual Parallel Trade for Pharma will be returning to London in February 2017 after 10 successful years in…
Case study from Maersk Oil North Sea: Financing a major gas project in a challen …
Recently in the news: ” Maersk Oil begins first production well drilling at $4.5bn Culzean field in UK North Sea”.(Source: EBR, 30th Sep 2016)
SMi Group…
Market Access Strategies – Pricing and Reimbursement Landscape in the European …
SMi Group reports: 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference will be returning to London next week.
Payers continue to play an important…
Solving the last jigsaws to minimize risks, optimize costs and accelerate commer …
It's without doubts that the biosimilars market present lucrative opportunities for pharmaceuticals and biotech companies. Over the last 12 months, market participants have witnessed revolutionary…
Critical Updates Showcased at Pre-Filled Syringes Europe 2017 by the MHRA, UCB, …
SMi Group are delighted to have the UK Medicines and Healthcare Products Agency (MHRA), present the latest updates on EU legislation in an opening address…
Early Bird Discount for Biometrics Masterclass Expiring end of September
SMi Group Reports (2016.09.28, London, UK): Savings for Biometrics in Official Environments and the Future Masterclass expiring soon
The £100 booking discount for SMi's security masterclass,…
Risk assessments in fungal spore and bacterial spore excursions
SMi Group reports: the 6th annual Pharmaceutical Microbiology conference will be returning to Holiday Inn Kensington Forum, London, UK on 18 – 19 January 2017.
The…
Interviews Released on Antibiotic Resistance with BARDA, Janssen and Blueberry T …
SMi Group release an exclusive series of interviews ahead of the Superbugs & Superdrugs USA Conference that will take place on Nov 14th and 15th.…
Biogen Talk Biosimilars in Keynote Address at Biosimilars Europe 2016
Following on from Biogen’s recent UK launch of its biosimilar drug for a range of chronic inflammatory conditions, SMi are thrilled to welcome them onto…
The RAF on Preparing ISR Operators for Current and Future Operations: Training D …
Effective training is vital for a robust and versatile ISR (Intelligence, Surveillance and Reconnaissance) capability. When developing the practices and technologies required for information superiority,…
Meet Top 10+ pharma companies at European Pharmaceutical Market Access, Pricing …
SMi’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference will be returning to London in 4 weeks.
This year’s packed programme includes unique presentations,…
Agenda released for the highly anticipated 6th annual Pharmaceutical Microbiolog …
SMi proudly presents the return of the 6th annual Pharmaceutical Microbiology conference and exhibition to Holiday Inn Kensington Forum, London on 18 - 19 January…
The Most Prominent Updates in Biosimilars Discussed by Merck, Lupin, IMS Health …
Just three weeks remain until the medical industry gathers for SMi’s established Biosismilars Europe show which will return to Central London on 29th and 30th…
3 Presentations on Tactical Communications by Hungarian Defence Forces, RUAG Def …
SMi reports (2016.09.06, London, United Kingdom): SMi Group have released online 3 presentations from the 9th annual Mobile Deployable Communications conference
SMi Group have released for…
Richard DiCicco from Harvest Moon Pharmaceuticals USA provides an Exclusive Inte …
It's without doubts that the biosimilars market present lucrative opportunities for pharmaceuticals and biotech companies. Over the last 12 months, market participants have witnessed revolutionary…
Santander, Sumitomo Mitsui Banking Corporation, ABN AMRO Bank, Standard Chartere …
SMi Group reports: The 3rd annual Project Financing in Oil and Gas conference will be returning to London on 21 – 22 November 2016.
The Project…
MQ-9 users USA, UK, France, Netherlands and Spain will meet in London to discuss …
SMi reports (2016.08.23, London, UK): Learn about Spain’s MQ-9 procurement deal with Spanish MoD representative presenting at this year’s Airborne ISR
IN THE NEWS: "Spain has…
Rafael, Lockheed Martin, Thales and Northrop Grumman meet in Prague to discuss A …
SMi reports (19.08.2016, London, UK): Leading defence vendors join the expert industry speaker line-up at the Air Missile Defence Technology conference this Autumn.
SMi has confirmed…
Vaccination Induced Cellular Immunity – The Novel Therapy Breakthrough against …
SMi Group are delighted to have Farzin Farzaneh, Professor of Molecular Medicine at Kings College London, open the 2016 Cancer Vaccines congress when it returns…
Case studies on drug development and novel targets from Glenmark Pharmaceuticals …
SMi Group reports: Glenmark Pharmaceuticals and Novartis Pharma to join the speaker line up at this years’ COPD conference in London on 19-20th October.
COPD 2016…
Cancer Vaccines: Abzena and Genentech go Under the Microscope in Exclusive New I …
SMi's 5th annual Cancer Vaccines conference will return to London this autumn to showcase the latest advances in clinical breakthroughs. In the run up to…
John Rex to Give Exclusive Talk on the Crisis of Antimicrobial Resistance
Industry expert Dr John Rex will be presenting a special keynote address on the global crisis of antibiotic resistance at SMi’s Superbugs & Superdrugs congress…
Exclusive Access to Helicopter Presentations by Royal Netherlands Air Force, Swe …
SMi reports (2016.07.27, London, United Kingdom): SMi releases exclusive access to past military helicopter presentations
SMi Group have released online three military presentations from the second…
CURRENT TRENDS IN HEALTH TECHNOLOGY ASSESMENT
SMi Group Reports: Quintiles, Alcon and Novartis to present their case studies on HTA at European Pharmaceutical Market Access, Pricing and Reimbursement (10 – 12…
Sandoz to Give Insight on European Biosimilar Trends at 7th Annual Congress
SMi Group are delighted to announce a new speaker for the two day event which will gather a global audience of biosimilar drug makers and…
How to finance your mega projects in such volatile market situation? Case Studie …
SMi reports (2016. 07.15, London, UK): Hear case studies from Maersk Oil North Sea UK and Genel Energy at the 3rd annual Project Financing Oil…
Case studies on drug development and novel targets from Glenmark Pharmaceuticals …
SMi Group reports: Glenmark Pharmaceuticals and Novartis Pharma to join the speaker line up at this years’ COPD conference in London on 19-20th October.
COPD 2016…
RBV Capital to explore venture capital partnerships in the orphan drugs industry
SMi Group reports (12.07.2016, London, UK): Venture capital fund partner joins expert speaker line-up at Orphan Drugs & Rare Diseases 2016
The industry established event “Orphan…
How to commercialize Biosimilars? Case studies from Boehringer Ingelheim, EMD Se …
SMi Group: Biosimilars North America meeting will take place on November 16-17, 2016, New Jersey, USA.
It's without doubts that the biosimilars market present lucrative…
Thales strengthens commitment to cybersecurity | Hear more at MilSocialMedia2016
SMi Reports (London, UK): Thales have joined the speaker line-up for SMi Group’s 6th annual Social Media within the Defence & Military Sector in November.
SMi…
Agenda Released for Superbugs USA: PAHO/WHO, NIH, AstraZeneca, Pfizer and BARDA …
SMi have announced that a brochure has been released for Superbugs & Superdrugs USA, taking place on November 14th & 15th 2016 in Iselin, New…
Biosimilars Europe: Looking Ahead into the New European Landscape
Case studies from both Switzerland and Norway on strategic management and switching studies with two keynotes from Merck Group and the Norwegian Medicines Agency.
SMi are…
Interview released with UBC – An Express Scripts Company: Patient Recruitment …
SMi Group: Biosimilars North America meeting will take place on November 16-17, 2016, New Jersey, USA.
In the run up to the event, the SMi Group…
Alexion to explore challenges in paediatric orphan drug development
SMi reports (29.06.2016, London, UK): Alexion Associate Director for Regulatory Affairs joins expert speaker line-up at the 5th Orphan Drugs and Rare Diseases event.
SMi…
Future Pricing and Reimbursement strategies from ABPI, IMS Health, Baxalta, Shir …
SMi Group’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference will be running at Holiday Inn, Kensington Forum in London from 10-11 October…
Project Financing in Oil and Gas is returning to London this November. Join Maer …
SMi Group is delighted to announce that registration is now live for the 3rd annual Project Financing in Oil and Gas conference (21- 22 November…
BARDA, NIH and Janssen to Present on Antimicrobial Resistance at Superbugs USA t …
SMi are delighted to announce the expansion of their antimicrobial portfolio of events across the Atlantic with the release of Superbugs & Superdrugs USA, complementing…
Exclusive New Interview Released with Biontech RNA Pharmaceuticals Prior to Keyn …
SMi are delighted to have Dr. Mustafa Diken from Biontech RNA Pharmaceuticals GmbH, present at the 5th Annual Cancer Vaccines Conference when it returns to…
Meet Respiratory Experts from Novartis, Chiesi, MedImmune and Mylan at COPD 2016
SMi Reports (2016.06.24, London, UK): The 8th annual COPD conference will be returning to London on 19 – 20 October 2016. Experts from Novartis, Chiesi,…
